Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Xin Yao

Oncology | Hematology
Cleveland Clinic Health System
Martin Memorial Medical Center Inc
10050 Sw Innovation Way, Suite 102, 
Port St Lucie, FL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Cleveland Clinic Health System
Martin Memorial Medical Center Inc
10050 Sw Innovation Way, Suite 102, 
Port St Lucie, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Xin Yao is an Oncologist and a Hematologist in Port St Lucie, Florida. Dr. Yao is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Colorectal Cancer, Thrombocytopenia, Familial Colorectal Cancer, and Lynch Syndrome. Dr. Yao is currently accepting new patients.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in FL
Hospital Affiliations
Cleveland Clinic Martin North Hospital
Languages Spoken
English
Mandarin
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

MARTIN MEMORIAL MEDICAL CENTER INC
10050 Sw Innovation Way, Suite 102, Port St Lucie, FL 34987
Call: 772-344-3811

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Drug, Procedure
Study Drug: Olaparib
Study Phase: Phase 2
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Suspended
Publish Date: October 10, 2025
Intervention Type: Biological, Drug, Procedure, Radiation
Study Drugs: Carboplatin, Ipilimumab, Nivolumab, Paclitaxel
Study Phase: Phase 2/Phase 3
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Phase: Phase 3
A Phase II Study of Neoadjuvant Nivolumab Plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma
A Phase II Study of Neoadjuvant Nivolumab Plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Procedure, Biological, Radiation
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug, Other
Study Drugs: Capecitabine, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 2/Phase 3
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: a Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: a Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: January 17, 2025
Intervention Type: Other, Drug
Study Drugs: Oxaliplatin, Duloxetine Hydrochloride, Duloxetine
Study Phase: Phase 2/Phase 3
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other, Dietary supplement, Drug
Study Drugs: Bevacizumab, Oxaliplatin, Leucovorin calcium, Fluorouracil, Irinotecan hydrochloride, Irinotecan
Study Phase: Phase 3
View 7 Less Clinical Trials

39 Total Publications

TNF-α -1031T/C and -863C/A polymorphisms are associated with dyslipidemia.
TNF-α -1031T/C and -863C/A polymorphisms are associated with dyslipidemia.
Journal: The British journal of nutrition
Published: July 31, 2025
View All 39 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Abraham Schwarzberg
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Abraham Schwarzberg
Hematology | Oncology

Cancer Center Of South Florida PLLC

1630 S Congress Ave, Suite 200, 
Palm Springs, FL 
 (48.1 miles away)
561-253-3980
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Abraham Schwarzberg is a Hematologist and an Oncologist in Palm Springs, Florida. Dr. Schwarzberg is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Vijay Narendran
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Vijay Narendran
Hematology | Oncology

Cancer Center Of South Florida PLLC

1630 S Congress Ave, Suite 200, 
Palm Springs, FL 
 (48.1 miles away)
561-253-3980
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vijay Narendran is a Hematologist and an Oncologist in Palm Springs, Florida. Dr. Narendran is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Thrombocytopenia, Large-Cell Immunoblastic Lymphoma, Anemia, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Heather Yeckes-Rodin
Hematology Oncology | Oncology | Hematology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Heather Yeckes-Rodin
Hematology Oncology | Oncology | Hematology

Hem Onc Associates Of The Treasure Coast, PA

1871 Se Tiffany Ave, Suite 100, 
Port Saint Lucie, FL 
 (8.3 miles away)
772-335-5666
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Heather Yeckes-Rodin is a Hematologist Oncology specialist and an Oncologist in Port Saint Lucie, Florida. Dr. Yeckes-Rodin is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Yeckes-Rodin is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yao's expertise for a condition
ConditionClose
      • Advanced
      • Adult Immune Thrombocytopenia
        Dr. Yao is
        Advanced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Agranulocytosis
        Dr. Yao is
        Advanced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Yao is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Anemia
        Dr. Yao is
        Advanced
        . Learn about Anemia.
        See more Anemia experts
      • Angiosarcoma
        Dr. Yao is
        Advanced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      • Breast Cancer
        Dr. Yao is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      View All 45 Advanced Conditions
      • Experienced
      • Acinic Cell Carcinoma of Salivary Glands
        Dr. Yao is
        Experienced
        . Learn about Acinic Cell Carcinoma of Salivary Glands.
        See more Acinic Cell Carcinoma of Salivary Glands experts
      • Acute Hepatic Porphyria (AHP)
        Dr. Yao is
        Experienced
        . Learn about Acute Hepatic Porphyria (AHP).
        See more Acute Hepatic Porphyria (AHP) experts
      • Acute Lymphoblastic Leukemia (ALL)
        Dr. Yao is
        Experienced
        . Learn about Acute Lymphoblastic Leukemia (ALL).
        See more Acute Lymphoblastic Leukemia (ALL) experts
      • Acute Monoblastic Leukemia (AmoL)
        Dr. Yao is
        Experienced
        . Learn about Acute Monoblastic Leukemia (AmoL).
        See more Acute Monoblastic Leukemia (AmoL) experts
      • Acute Myeloblastic Leukemia with Maturation
        Dr. Yao is
        Experienced
        . Learn about Acute Myeloblastic Leukemia with Maturation.
        See more Acute Myeloblastic Leukemia with Maturation experts
      • Acute Myeloblastic Leukemia without Maturation
        Dr. Yao is
        Experienced
        . Learn about Acute Myeloblastic Leukemia without Maturation.
        See more Acute Myeloblastic Leukemia without Maturation experts
      View All 125 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved